Arkolith/Insider Trading/AMLX/Form 4

Mazzariello Gina

Chief Legal OfficerAmylyx Pharmaceuticals, Inc. (AMLX) · full profile →Form 4 · filed Jul 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$539K
Net Open-Market Flow
-$539K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2026Sell(S)15K$17.61$264K179K
Jul 9, 2026Sell(S)15K$18.32$275K194K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-301996) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML